Address:
Office: Professor, Mathematics Discipline, Khulna University, Khulna-9208, Bangladesh Residence: 1W/ Milimishi, House No. 10, Road No. 2, Prantika Residential Area, Khulna. Bangladesh
Email:
sfahmmed@math.ku.ac.bd
Contact:
01712195877.
Personal Webpage:
click hereNumerical Simulation of Nano Second Grade Fluid Flow Under the Impression of Nonlinear Radiation and Periodic Magnetic Field
1.
This study aims to enhance the
comprehension of the fundamental fluid behavior by comparing Newtonian fluid
with second-grade fluid under the influence of periodic magnetic fields,
nonlinear radiative nanomaterial, and a porous stretched surface featuring a
heat source. The governing equations' dimensionless forms are generated by
applying the proper transformations, and the explicit finite difference (EFD)
method is used to solve the numerically-derived solution while carefully
maintaining stability and convergence standards. The results include velocity,
heat, and mass transfer oscillation profiles; streamlines, and isothermal
lines. Nusselt and Sherwood numbers are correlated with different factors
according to tabular studies, and data prediction and regression are done using
graphical representations. This study revealed that, in contrast to Newtonian
fluid, second-grade fluid flow elevates velocity profiles with variations in
chemical reaction parameters and mass Grashof numbers. Conversely, the thermal
non-linear radiation and heat source in second-grade fluid particles
effectively enhance the temperature field, although the temperature increase is
more pronounced in Newtonian fluid compared to second-grade fluid. Also,
second-grade fluid flow exhibits a lower mass transmission rate but higher
stress sharing and heat transmission rates compared to Newtonian fluid flow.
The implications of this research may impact prostate cancer treatment, as
cancer patients have already benefited from the use of magnetic fields to
regulate drug release from nanoparticles.
Although
the greater stress sharing and heat transmission rates may be used for targeted
therapy, the lower mass transmission rate raises the possibility of benefits in
controlled release scenarios.
| Details | |||
| Role | Principal Investigator | ||
|---|---|---|---|
| Funding Agency | National | ||
| Awarded Date | 01 July 2023 | ||
| Completion Date | 30 July 2024 | ||